News

Transpire Bio press releases

Transpire Bio Enters into Exclusive License Agreement with Suzhou Intragrand Pharma for Investigational PDE4 Inhibitor

Transpire Bio Announces R&D and Manufacturing Expansion

Transpire Bio Strengthens Leadership Team with New Appointments to Lead Commercialization, Quality Assurance, and Manufacturing

Transpire Bio Achieves Important Corporate Milestone with Dosing of First Human Subject in the Company’s Asthma and Chronic Obstructive Pulmonary Disease Inhaled Drug Program

Transpire Bio Expands Access and Innovation in Inhalation Therapies with New Research and Manufacturing Facility

Transpire Bio announces agreement with INTO for the development of three inhaled medicines

Transpire Bio Strengthens Its Leadership Team with a New Senior-Level Appointment

Transpire Bio announces agreement with Recipharm for the development of an inhaled medicine